BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37772700)

  • 1. A new, all-encompassing aetiology of type 1 diabetes.
    de Groen PC
    Immunology; 2024 Jan; 171(1):77-91. PubMed ID: 37772700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
    Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
    BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium.
    Wägner AM; Santana A; Herńndez M; Wiebe JC; Nóvoa J; Mauricio D;
    Diabetes Metab Res Rev; 2011 Jul; 27(5):493-8. PubMed ID: 21744463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
    Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
    Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.
    Miyadera H; Tokunaga K
    J Hum Genet; 2015 Nov; 60(11):697-702. PubMed ID: 26290149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).
    Wagner DH
    Clin Exp Immunol; 2016 Sep; 185(3):271-80. PubMed ID: 27271348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope.
    Dahan R; Gebe JA; Preisinger A; James EA; Tendler M; Nepom GT; Reiter Y
    J Autoimmun; 2013 Dec; 47():83-93. PubMed ID: 24090977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.
    Yang J; Chow IT; Sosinowski T; Torres-Chinn N; Greenbaum CJ; James EA; Kappler JW; Davidson HW; Kwok WW
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14840-5. PubMed ID: 25267644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide.
    Wiles TA; Hohenstein A; Landry LG; Dang M; Powell R; Guyer P; James EA; Nakayama M; Haskins K; Delong T; Baker RL
    Front Immunol; 2021; 12():668680. PubMed ID: 34113344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.
    Busch R; De Riva A; Hadjinicolaou AV; Jiang W; Hou T; Mellins ED
    Expert Rev Mol Med; 2012 Jul; 14():e15. PubMed ID: 22805744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes.
    Bronson PG; Ramsay PP; Thomson G; Barcellos LF;
    Diabetes Obes Metab; 2009 Feb; 11 Suppl 1(Suppl 1):74-83. PubMed ID: 19143818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
    Ge X; James EA; Reijonen H; Kwok WW
    J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.
    Miyadera H; Ohashi J; Lernmark Å; Kitamura T; Tokunaga K
    J Clin Invest; 2015 Jan; 125(1):275-91. PubMed ID: 25485681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell epitopes of the La/SSB autoantigen: prediction based on the homology modeling of HLA-DQ2/DQ7 with the insulin-B peptide/HLA-DQ8 complex.
    Kosmopoulou A; Vlassi M; Stavrakoudis A; Sakarellos C; Sakarellos-Daitsiotis M
    J Comput Chem; 2006 Jul; 27(9):1033-44. PubMed ID: 16639700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes.
    Golden B; Levin L; Ban Y; Concepcion E; Greenberg DA; Tomer Y
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4904-11. PubMed ID: 15928253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes.
    Pathiraja V; Kuehlich JP; Campbell PD; Krishnamurthy B; Loudovaris T; Coates PT; Brodnicki TC; O'Connell PJ; Kedzierska K; Rodda C; Bergman P; Hill E; Purcell AW; Dudek NL; Thomas HE; Kay TW; Mannering SI
    Diabetes; 2015 Jan; 64(1):172-82. PubMed ID: 25157096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of HLA class I-restricted T-cell epitopes of islet autoantigen combined with binding and dissociation assays.
    Wu X; Xu X; Gu R; Wang Z; Chen H; Xu K; Zhang M; Hutton J; Yang T
    Autoimmunity; 2012 Mar; 45(2):176-85. PubMed ID: 22260783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.
    Wang Y; Sosinowski T; Novikov A; Crawford F; Neau DB; Yang J; Kwok WW; Marrack P; Kappler JW; Dai S
    Proc Natl Acad Sci U S A; 2018 Jan; 115(1):162-167. PubMed ID: 29255035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.
    Lombardi A; Concepcion E; Hou H; Arib H; Mezei M; Osman R; Tomer Y
    J Autoimmun; 2020 Dec; 115():102543. PubMed ID: 32951964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.